Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. RPG Life Sciences Limited
WARNING LETTER
•RPG Life Sciences Limited•January 31, 2013

RPG Life Sciences Limited – FDA Warning Letter, Jan 31, 2013

Record Details

The FDA issued a Warning Letter to RPG Life Sciences Limited following inspections of their Ankleshwar (November 20-24, 2012) and Navi Mumbai (January 28-31, 2013) facilities, identifying significant CGMP violations for finished pharmaceuticals and APIs, respectively. These violations render their products adulterated under Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act.

At MS-Ankleshwar, violations included failure to investigate OOS results (21 CFR 211.192), such as stability assay failures and impurity exceedances, with the firm selectively reporting passing retest values and lacking documentation for retrospective investigations. The firm also failed to follow laboratory control mechanisms (21 CFR 211.160(a)), discarding raw data and using multiple HPLC processing methods without justification. Additionally, laboratory records lacked complete data (21 CFR 211.194(a)), with raw data for sample preparations missing and "trial" injections not documented. Controls over computer systems were inadequate (21 CFR 211.68(b)), allowing analysts to delete and overwrite electronic data and backdate records.

At MS-Navi Mumbai, the firm failed to investigate and document OOS results (e.g., stability assays exceeding impurity limits), discarding raw data and lacking scientific evidence for root causes. Complaint

Company
RPG Life Sciences Limited
Inspection date
January 31, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Michael D. Smedley
  • Allison Aldridge
View Company Profile

ID · 87b5115a-763f-471b-aeac-f57f051eb1a3

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.160(a)21 CFR 211.194(a)21 CFR 211.68(b)21 U.S.C. 381(a)(3)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore RPG Life Sciences Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.